Co-Authors
This is a "connection" page, showing publications co-authored by DAVID HUI and KIMBERSON COCHIEN TANCO.
Connection Strength
1.672
-
The impact of a web-based prognostic calculator on prognostic confidence in outpatient palliative care. Support Care Cancer. 2024 Oct 08; 32(11):714.
Score: 0.246
-
Neuroleptic strategies for terminal agitation in patients with cancer and delirium at an acute palliative care unit: a single-centre, double-blind, parallel-group, randomised trial. Lancet Oncol. 2020 07; 21(7):989-998.
Score: 0.182
-
Chronic Non-Malignant Pain in Patients with Cancer Seen at a Timely Outpatient Palliative Care Clinic. Cancers (Basel). 2020 Jan 15; 12(1).
Score: 0.177
-
Testing the feasibility of using the Edmonton Symptom Assessment System (ESAS) to assess caregiver symptom burden. Palliat Support Care. 2018 Feb; 16(1):14-22.
Score: 0.145
-
Access to palliative care among patients treated at a comprehensive cancer center. Oncologist. 2012; 17(12):1574-80.
Score: 0.108
-
Targeted agent use in cancer patients at the end of life. J Pain Symptom Manage. 2013 Jul; 46(1):1-8.
Score: 0.108
-
Perceptions Toward Naloxone Among Patients With Cancer Receiving Opioids. J Pain Symptom Manage. 2024 Dec; 68(6):e500-e507.
Score: 0.061
-
Correction to: MASCC guideline: cannabis for cancer-related pain and risk of harms and adverse events. Support Care Cancer. 2023 May 06; 31(6):323.
Score: 0.056
-
Helpfulness of Question Prompt Sheet for Patient-Physician Communication Among Patients With Advanced Cancer: A Randomized Clinical Trial. JAMA Netw Open. 2023 05 01; 6(5):e2311189.
Score: 0.056
-
MASCC guideline: cannabis for cancer-related pain and risk of harms and adverse events. Support Care Cancer. 2023 Mar 06; 31(4):202.
Score: 0.055
-
Multinational Association of Supportive Care in Cancer (MASCC) guidelines: cannabis for psychological symptoms including insomnia, anxiety, and depression. Support Care Cancer. 2023 Feb 21; 31(3):176.
Score: 0.055
-
Levorphanol as a Second Line Opioid in Cancer Patients Presenting to an Outpatient Supportive Care Center: An Open-label Study. J Pain Symptom Manage. 2023 06; 65(6):e683-e690.
Score: 0.055
-
Multinational Association of Supportive Care in Cancer (MASCC) expert opinion/consensus guidance on the use of cannabinoids for gastrointestinal symptoms in patients with cancer. Support Care Cancer. 2022 Dec 16; 31(1):39.
Score: 0.054
-
Opioid Rotation and Conversion Ratios Used by Palliative Care Professionals: An International Survey. J Palliat Med. 2022 Oct; 25(10):1557-1562.
Score: 0.053
-
A retrospective review of the use of oxymorphone immediate release for long term pain control in cancer patients with gastrostomy tubes. Ann Palliat Med. 2021 Mar; 10(3):2662-2667.
Score: 0.048
-
Random urine drug testing among patients receiving opioid therapy for cancer pain. Cancer. 2021 03 15; 127(6):968-975.
Score: 0.047
-
Association between tobacco use, pain expression, and coping strategies among patients with advanced cancer. Cancer. 2019 01 01; 125(1):153-160.
Score: 0.041
-
Association Between Tobacco Use, Symptom Expression, and Alcohol and Illicit Drug Use in Advanced Cancer Patients. J Pain Symptom Manage. 2016 Apr; 51(4):762-768.
Score: 0.033
-
Frequency, Predictors, and Medical Record Documentation of Chemical Coping Among Advanced Cancer Patients. Oncologist. 2015 Jun; 20(6):692-7.
Score: 0.032
-
The routine use of the Edmonton Classification System for Cancer Pain in an outpatient supportive care center. Palliat Support Care. 2015 Oct; 13(5):1185-92.
Score: 0.031
-
Chemical coping versus pseudoaddiction in patients with cancer pain. Palliat Support Care. 2014 Oct; 12(5):413-7.
Score: 0.029